NEW YORK (GenomeWeb) – VC firm Harris & Harris Group today announced the formation of Tara Biosystems, which is developing organ-on-a-chip technology for evaluating new therapies and drug compounds.

Harris & Harris has invested an undisclosed amount into Tara Bio. The company will initially use its organ-on-a-chip platform to provide physiologically relevant heart-on-a-chip human tissue models for toxicology and new drug discovery applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.